IN2012DN03631A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03631A IN2012DN03631A IN3631DEN2012A IN2012DN03631A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A IN 3631DEN2012 A IN3631DEN2012 A IN 3631DEN2012A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A
- Authority
- IN
- India
- Prior art keywords
- canines
- eye
- carotenes
- amounts
- maladies
- Prior art date
Links
- 241000282465 Canis Species 0.000 abstract 4
- 150000001746 carotenes Chemical class 0.000 abstract 2
- 235000005473 carotenes Nutrition 0.000 abstract 2
- 208000002177 Cataract Diseases 0.000 abstract 1
- 208000020564 Eye injury Diseases 0.000 abstract 1
- 201000007737 Retinal degeneration Diseases 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000004258 retinal degeneration Effects 0.000 abstract 1
- 230000003997 social interaction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28017509P | 2009-10-30 | 2009-10-30 | |
| PCT/US2010/002815 WO2011059474A1 (en) | 2009-10-30 | 2010-10-22 | Methods for maintaining eye health and ameliorating opthalmic maladies in canines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03631A true IN2012DN03631A (pl) | 2015-06-26 |
Family
ID=43991896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3631DEN2012 IN2012DN03631A (pl) | 2009-10-30 | 2010-10-22 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120270954A1 (pl) |
| EP (1) | EP2493293B1 (pl) |
| JP (1) | JP6071554B2 (pl) |
| CN (1) | CN102686107A (pl) |
| AU (1) | AU2010318687B2 (pl) |
| BR (1) | BR112012010179A2 (pl) |
| CA (1) | CA2778229A1 (pl) |
| ES (1) | ES2566652T3 (pl) |
| IN (1) | IN2012DN03631A (pl) |
| MX (1) | MX2012004777A (pl) |
| RU (1) | RU2012122169A (pl) |
| WO (1) | WO2011059474A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6026719B2 (ja) * | 2010-08-31 | 2016-11-16 | 株式会社ダイセル | 視機能予防・改善剤 |
| WO2013043366A1 (en) * | 2011-09-20 | 2013-03-28 | Nestec S.A. | Methods and compositions for improving visual function and eye health |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2094060C1 (ru) * | 1994-03-22 | 1997-10-27 | Уфимский научно-исследовательский институт глазных болезней | Глазная мазь |
| NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
| US20020110604A1 (en) * | 2000-08-11 | 2002-08-15 | Ashni Naturaceuticals, Inc. | Composition exhibiting synergistic antioxidant activity |
| US20020182736A1 (en) * | 2001-04-02 | 2002-12-05 | Trustees Of Tufts College | Methods to measure lipid antioxidant activity |
| CN100469776C (zh) | 2002-05-17 | 2009-03-18 | 奥特拉控股公司 | 白内障和其它眼病发展的改善 |
| TR201815573T4 (tr) | 2002-05-28 | 2018-11-21 | Astrazeneca Ab | Topikal olarak uygulanabilir farmasötik preparasyon. |
| CA2556223A1 (en) * | 2004-03-10 | 2005-09-22 | Trustees Of Tufts College | Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene |
| JP2008515778A (ja) * | 2004-08-18 | 2008-05-15 | シリオン セラピューティクス， インコーポレイテッド | 眼の状態を１３−シス−レチニル誘導体で処置するための組み合わせ方法、組成物および治療 |
| WO2006116755A2 (en) * | 2005-04-28 | 2006-11-02 | Trustees Of Tufts College | Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function |
| AU2007273955B2 (en) * | 2006-06-08 | 2012-09-06 | Mars, Incorporated | Composition for improving eye health |
| US8158667B2 (en) | 2006-08-21 | 2012-04-17 | Kador Peter F | Topical treatment of cataracts in dogs |
| KR20100096094A (ko) | 2007-10-19 | 2010-09-01 | 가부시키가이샤 아루떼꾸 우에노 | 백내장 처치를 위한 의약 조성물 |
| WO2009100331A2 (en) * | 2008-02-06 | 2009-08-13 | The Procter & Gamble Company | Compositions methods and kits for enhancing immune response to a respiratory condition |
-
2010
- 2010-10-22 IN IN3631DEN2012 patent/IN2012DN03631A/en unknown
- 2010-10-22 BR BR112012010179A patent/BR112012010179A2/pt not_active Application Discontinuation
- 2010-10-22 MX MX2012004777A patent/MX2012004777A/es active IP Right Grant
- 2010-10-22 ES ES10830307.4T patent/ES2566652T3/es active Active
- 2010-10-22 JP JP2012536786A patent/JP6071554B2/ja not_active Expired - Fee Related
- 2010-10-22 US US13/503,953 patent/US20120270954A1/en not_active Abandoned
- 2010-10-22 RU RU2012122169/13A patent/RU2012122169A/ru unknown
- 2010-10-22 WO PCT/US2010/002815 patent/WO2011059474A1/en not_active Ceased
- 2010-10-22 CA CA2778229A patent/CA2778229A1/en not_active Abandoned
- 2010-10-22 AU AU2010318687A patent/AU2010318687B2/en not_active Ceased
- 2010-10-22 CN CN2010800595322A patent/CN102686107A/zh active Pending
- 2010-10-22 EP EP10830307.4A patent/EP2493293B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012122169A (ru) | 2013-12-10 |
| JP2013509407A (ja) | 2013-03-14 |
| AU2010318687B2 (en) | 2016-02-25 |
| US20120270954A1 (en) | 2012-10-25 |
| BR112012010179A2 (pt) | 2015-09-29 |
| MX2012004777A (es) | 2012-06-01 |
| AU2010318687A1 (en) | 2012-05-24 |
| CN102686107A (zh) | 2012-09-19 |
| WO2011059474A1 (en) | 2011-05-19 |
| JP6071554B2 (ja) | 2017-02-01 |
| EP2493293A4 (en) | 2013-03-20 |
| EP2493293A1 (en) | 2012-09-05 |
| CA2778229A1 (en) | 2011-05-19 |
| EP2493293B1 (en) | 2016-03-02 |
| ES2566652T3 (es) | 2016-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Melia et al. | Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3 | |
| ECSP099516A (es) | Composición suplementaria nutricional para el tratamiento de enfermedades oculares | |
| MY176679A (en) | Use of nutritional compositions for preventing disorders | |
| WO2012158910A3 (en) | Compositions and methods for treating retinal diseases | |
| MX2010006422A (es) | Proteinas de union a antigenos. | |
| MX2009006342A (es) | Composicion de complemento alimenticio para tratamiento de enfermedades oculares. | |
| WO2011053803A3 (en) | Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders | |
| PH12018500401B1 (en) | Antibodies specific for tgf-beta | |
| PH12013500808A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| WO2010105728A3 (en) | Active retinal implant | |
| PL2262476T3 (pl) | Dostarczanie leku do przedniego i tylnego odcinka oka z użyciem kropli do oczu | |
| MX2007008848A (es) | Metodos y composiciones para el tratamiento de desordenes oculares. | |
| EP3335710A3 (en) | Use of nutritional compositions for preventing disorders | |
| CL2008003120A1 (es) | Compuestos derivados de fenilalquil-, fenilalquenil-, fenilalquinil- amina, feniltioalquilamina, fenilaminoalquilamina, fenilalcoxiamina y fenilalquilguanidina; composicion farmaceutica; y uso de los compuestos para tratar un trastorno o enfermedad oftalmologica tal como retinopatia, maculopatia, retinitis pigmentosa, uveitis, entre otras. | |
| SG156649A1 (en) | Crig polypeptide for prevention and treatment of complement-associated disorders | |
| PH12018500767A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| TN2010000566A1 (en) | Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs | |
| WO2011151685A8 (en) | N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament | |
| WO2007135426A3 (en) | Treatment of neurodegeneratives diseases | |
| MX347263B (es) | Metodos para incrementar la produccion o actividad de catalasa. | |
| MX2007010752A (es) | Usos oftalmicos de moduladores de receptor s1p. | |
| WO2010101301A9 (en) | Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein | |
| MX2009005503A (es) | Uso de l-carnitina para la preparacion de un medicamento en forma de gotas oculares para el tratamiento de enfermedades de la cornea. | |
| WO2007042040A3 (en) | TREATMENT OF RETINOPATHIES USING GFRα3 AGONISTS | |
| BR112012010179A2 (pt) | métodos para manter a saúde do olho e melhorar as doenças oftálmicas em caninos. |